AF
DMTK

Amalgamated Financial’s DermTech, Inc. Common Stock DMTK Stock Holding History

Amalgamated Financial’s Portfolio DMTK Stock Details DMTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		$58K Buy
+3,965
New +$53.1K ﹤0.01% 2356

Other funds holding DMTK

RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Casdin Capital New York $1.32B AUM 76.62% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
ICM
Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return
OIM
Oracle Investment Management Greenwich, Connecticut $168M AUM 42.86% 1-Year Est. Return
AAMU
AEGON Asset Management (UK) Edinburgh, United Kingdom $9.38B AUM 48.94% 1-Year Est. Return

Amalgamated Financial's DMTK Position: Q1 2022 in Review

Amalgamated Financial opened a new position in DermTech, Inc. Common Stock (DMTK) in Q1 2022: 3,965 shares worth $58K. The stake represents ﹤0.01% of the portfolio and ranks #2356 among its holdings.

151 funds tracked by Wall St. Rank hold DMTK as of Q1 2022.

  • Amalgamated Financial held 3,965 shares of DermTech, Inc. Common Stock worth $58K as of Q1 2022.
  • DermTech, Inc. Common Stock was a new Amalgamated Financial position in Q1 2022.
  • DermTech, Inc. Common Stock made up ﹤0.01% of Amalgamated Financial's portfolio in Q1 2022, its #2356 holding.
  • 151 funds tracked by Wall St. Rank held DermTech, Inc. Common Stock as of Q1 2022.

Based on Amalgamated Financial's 13F filing for Q1 2022, filed 16 May 2022.